Shipments are expected to begin immediately. Earlier in the year, Able Labs announced that it entered into an ANDA Transfer and Marketing Agreement with IVAX Pharmaceuticals, Inc. Eon Labs is a generic pharmaceutical company specializing in developing, licensing, manufacturing, selling and distributing a broad range of prescription pharmaceutical products. Mylan Laboratories Inc. , is a leading pharmaceutical company that develops, manufacturers and markets generic and proprietary prescription pharmaceutical products. Johnson's Ultram(R), 50mg generic ultram is approximately $550 million according to the IMS Data. Food and Drug Administration has approved its Abbreviated New Drug Application 50mg generic ultram (anda) for Tramadol Hydrochloride Tablets, 50 mg. Such statements are based on current plans, estimates and expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's future results, performance or achievements to differ significantly from the results, performance or achievements expressed or implied by such forward-looking statements.
Shipments are expected 50mg generic ultram to begin immediately. Private Securities Litigation Reform Act of 1995: This release contains statements that are forward-looking in nature which express the beliefs and 50mg generic ultram expectations of management. For example, statements about the Company's operations, capital-raising transactions and financial accounting, the current or expected market size for its products, the success of current or future product offerings, the research and development efforts and the Company's ability to file for and obtain U. Mylan's Tramadol product 50mg generic ultram is the generic version of R. The Company assumes no obligation to update its forward-looking statements to reflect new information and developments. (Nasdaq: TEVA) 50mg generic ultram announced today that the U. A wholly owned subsidiary of IVAX Corporation (AMEX:IVX) (LSE:IVX. 50mg generic ultram l) for Able Labs' Tramadol Hydrochloride Tablets. (NYSE:MYL) announced today that the 50mg generic ultram u.
To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking statements regarding our anticipated financial results and estimates, business prospects and products in research and under going development, all of which involve substantial risks and uncertainties. Eon's 50mg generic ultram diverse product line includes over 90 generic pharmaceutical products. The statements 50mg generic ultram are inherently uncertain, and actual results could differ materially from the statements made herein. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Tablets, 50mg. Such risks and uncertainties are not predictable or quantifiable; consequently, should known or unknown risks or uncertainties materialize, or should our assumptions or estimates prove inaccurate, actual results could differ materially from those expressed or implied by such forward-looking statement.